The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Cefuroxime Milpharm 500mg Film-coated tablets



Aurobindo Pharma (Malta) LimitedPA1445/022/002

Main Information

Trade NameCefuroxime Milpharm 500mg Film-coated tablets
Active SubstancesCefuroxime axetil (amorphous)
Dosage FormFilm-coated tablet
Licence HolderAurobindo Pharma (Malta) Limited
Licence NumberPA1445/022/002

Group Information

ATC CodeJ01DA CEPHALOSPORINS AND RELATED SUBSTANCES

Status

License statusAuthorised
Licence Issued23/10/2015
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back